Polymerase chain reaction identification of coagulase-negative staphylococci and of strain diversity and spread of Staphylococcus epidermidis in a major medical center in Lebanon

Infection Control and Hospital Epidemiology

Volumn 27, Issue 7, 2006, Pages 781-783

  Abdallah, Inaya M ^a   Araj, George F ^a   Matar, Ghassan M ^a   Abdelnour, George ^b   Uwaydah, Marwan ^a   Abdelnoor, Alexander M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b Hôpital Notre Dame de Secours   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; ELECTROPHORESIS; HOSPITAL; INFECTION CONTROL; LEBANON; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

BASE SEQUENCE; COAGULASE; DNA PRIMERS; HUMANS; LEBANON; POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33747676001     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/505093     Document Type: Article

References (13)

1. Arbeit RD. Laboratory procedures for epidemiological analysis. In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease. New York; Churchill Livingston; 1997:253-286.
2. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the sentry antimicrobial surveillance program. 1997-1999. Clin Infect Dis 2001; 32(Suppl):114-132.
3. Matar GM, Hébert GA, Uwaydah, M. Characteristics of nosocomial versus outpatient isolates of coagulase-negative Staphylococci at a Medical Center in Beirut Lebanon. Leb Sci Bull 1995; 8:63-75.
4. Huebner J, Goldmann DA. Coagulase-negative Staphylococci: role as pathogens. Ann Rev Med 1999; 50:223-236.
5. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med Suppl 2002; 113:14S-19S.
6. Peters G, Von Eiff C, Herrmann M. The changing pattern of coagulase-negative Staphylococci as infectious pathogens. Curr Opin Infect Dis 1995; 8(Suppl 1):S12-S19.
7. Patrick CC. Coagulase-negative Staphylococci: pathogens with increasing clinical significance. J Pediatr 1990; 116:497-507.
8. Martin MA, Pfaller A, Wenzel RP. Coagulase-negative staphylococcal bacteremia. Ann Intern Med 1989; 110:9-16.
9. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1:281-299.
10. Mendoza M, Meugnier HM, Etienne J, Freney J. Identification of Staphylococcus species by 16S-23S rDNA intergenic spacer PCR analysis. Int J Syst Bacteriol 1998; 48:1049-1055.
11. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing. 12th suppl. M100-S12. Vilanova, PA: NCCLS; 2002.
12. Martineau F, Picard FJ, Danbing KE, et al. Development of a PCR assay for identification of staphylococci at genus and species level. J Clin Microbiol 2001; 39:2541-2547.
13. Matar GM, Chaar MH, Araj GF, Srour Z, Jamaleddine G, Hadi U. Detection of a highly prevalent and potentially virulent strain of Pseudomonas aeruginosa from nosocomial infections in a medical center. BMC Microbiol 2005; 5:29.